Fulgent Genetics (FLGT) Change in Cash (2015 - 2026)

Fulgent Genetics has disclosed Change in Cash across 12 years of filings, most recently posting $2.9 million for Q2 2026.

• In Q2 2026, Change in Cash fell 85.89% year-over-year to $2.9 million; the TTM figure through Jun 2026 stood at -$61.6 million (down 368.84% YoY), while the FY2025 annual figure was -$5.0 million, up 88.27% from the prior year.
• Change in Cash came in at $2.9 million for Q2 2026 at Fulgent Genetics, up from -$26.8 million in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $188.2 million in Q1 2022 to a low of -$214.3 million in Q2 2022.
• Average Change in Cash over 5 years is -$7.7 million, with a median of $4000.0 recorded in 2024.
• The largest YoY upside for Change in Cash was 529.2% in 2025 against a maximum downside of 2227.4% in 2025.
• Over 5 years, Change in Cash stood at -$89.3 million in 2022, then soared by 115.01% to $13.4 million in 2023, then sank by 121.63% to -$2.9 million in 2024, then tumbled by 2227.4% to -$67.4 million in 2025, then surged by 104.31% to $2.9 million in 2026.
• Per Business Quant data, the three most recent Change in Cash figures were $2.9 million in Q2 2026, -$26.8 million in Q1 2026, and -$67.4 million in Q4 2025.